Saroja Pharma Industries India Ltd.
SAROJA
Saroja Pharma Industries India Ltd.
SAROJA
Saroja Pharma Industries India Ltd. Share Price
39.70 -1.85 (-4.45%)Fundamentals
Market Cap₹17Cr | EPS₹4.01 |
Industry P/E (TTM)49.11 | Long Term D/E0.60 |
ROE6.82% | Dividend Yield (TTM)0.00% |
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Saroja Pharma Industries India Ltd.
The share price of Saroja Pharma Industries India Ltd. is ₹39.70 on NSE as of 28/8/2026, 6:27:10 pm. Share prices may change frequently due to market movements.
The market capitalisation of Saroja Pharma Industries India Ltd. is ₹17Cr as of 28/8/2026, 6:27:10 pm
The current Price to Earnings (P/E) ratio of Saroja Pharma Industries India Ltd. is 0.00 as of 28/8/2026, 6:27:10 pm
The Price to Book (P/B) ratio of Saroja Pharma Industries India Ltd. stands at 0.00 as of 28/8/2026, 6:27:10 pm
Saroja Pharma Industries India Ltd. reported an ROE of 6.82% for the last reported financial year on a consolidated account basis.
As of 28/8/2026, 6:27:10 pm, Saroja Pharma Industries India Ltd.’s shareholding pattern is: promoters hold 73.00%, FIIs hold 0.00%, DIIs hold 0.00%, and public shareholders hold 27.00%.
The 52-week high of Saroja Pharma Industries India Ltd. is ₹39.75 and the 52-week low is ₹39.70 as of 28/8/2026, 6:27:10 pm.
The stock symbol of Saroja Pharma Industries India Ltd. is SAROJA.
You can buy Saroja Pharma Industries India Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
The fair value of Saroja Pharma Industries India Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 70.13 | +30.52% |
| Other Income | 0.11 | -42.11% |
| Total Income | 70.24 | +30.29% |
| Total Expenditure | 68.00 | +29.62% |
| EBIDT | 3.81 | +28.28% |
| Depreciation | 0.11 | 0.00% |
| Interest | 1.46 | +3.55% |
| Tax | 0.62 | +47.62% |
| Net Profit | 1.62 | +57.28% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 18.56 |
| Total Non-Current Assets | 23.19 |
| Fixed assets | 22.52 |
| Total Assets | 41.75 |
| Total Current liabilities | 17.09 |
| Total Non Current Liabilities | 7.36 |
| Total Equity Plus Liabilities | 41.75 |
| Total Shareholder Funds | 17.29 |
| Total Debt to Equity | 83.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 7.44 |
| Cash from Financing Activities | 4.25 |
| Cash from Investing Activities | -11.72 |
| Net Cash Flow | -0.04 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages16
Bearish Moving Averages0
5 Day
37.9010 Day
34.5020 Day
32.7030 Day
32.6050 Day
32.10100 Day
36.70150 Day
38.40200 Day
41.20Indicators
RSI (14)
75.12MACD (12, 26)
1.71MACD Signal Line (9)
0.45MFI (14)
89.81ATR (14)
1.36ADX (14)
23.01ROC (21)
28.24ROC (125)
15.58Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 41.67 | 41.78 | 41.87 | 41.58 | 41.47 | 41.38 | 41.27 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 70.13 | +30.52% |
| Other Income | 0.11 | -42.11% |
| Total Income | 70.24 | +30.29% |
| Total Expenditure | 68.00 | +29.62% |
| EBIDT | 3.81 | +28.28% |
| Depreciation | 0.11 | 0.00% |
| Interest | 1.46 | +3.55% |
| Tax | 0.62 | +47.62% |
| Net Profit | 1.62 | +57.28% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 18.56 |
| Total Non-Current Assets | 23.19 |
| Fixed assets | 22.52 |
| Total Assets | 41.75 |
| Total Current liabilities | 17.09 |
| Total Non Current Liabilities | 7.36 |
| Total Equity Plus Liabilities | 41.75 |
| Total Shareholder Funds | 17.29 |
| Total Debt to Equity | 83.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 7.44 |
| Cash from Financing Activities | 4.25 |
| Cash from Investing Activities | -11.72 |
| Net Cash Flow | -0.04 |
Saroja Pharma Industries India Ltd.
SAROJA
Open Price | 39.75 |
Prev Close | 41.55 |
Upper Circuit | 43.60 |
Lower Circuit | 39.50 |
Volume | 3,200 |
Average Traded Price | 39.72 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |